MiRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Chu, Rui ^a   Mo, Guangquan ^a   Duan, Zhijun ^a   Huang, Mei ^a   Chang, Jiuyang ^a   Li, Xiaodong ^a   Liu, Pixu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; miRNA; miRNA biogenesis; Molecular mechanism

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PRE MICRORNA; PRI MICRORNA; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; BIOGENESIS; CANCER RISK; CELL CYCLE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC REGULATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METASTASIS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SYNTHESIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION; TUMOR VASCULARIZATION; ACTIVE TRANSPORT; ANIMAL; CARCINOGENESIS; CELL NUCLEUS; CELL PROLIFERATION; GENETIC POLYMORPHISM; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION;

EID: 84905274296     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-014-0045-y     Document Type: Article

References (108)

1. Molecular viral oncology of hepatocellular carcinoma. TM Block, AS Mehta, CJ Fimmel, R Jordan, Oncogene 2003 22 5093 5107 12910247 (Pubitemid 37059591)
2. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer. DF Calvisi, SS Thorgeirsson, Toxicol Pathol 2005 33 181 184 15805070 (Pubitemid 40216817)
3. Epidemiology of hepatocellular carcinoma. FX Bosch, J Ribes, R Cleries, M Diaz, Clin Liver Dis 2005 9 191 211 15831268
4. The role of microRNAs in liver cancer. I Papaconstantinou, A Karakatsanis, M Gazouli, G Polymeneas, D Voros, Eur J Gastroenterol Hepatol 2012 24 223 228 22228372
5. Mechanisms of control of microRNA biogenesis. BN Davis-Dusenbery, A Hata, J Biochem 2010 148 381 392 20833630
6. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. AE Pasquinelli, Nat Rev Genet 2012 13 271 282 22411466
7. RNA polymerase III transcribes human microRNAs. GM Borchert, W Lanier, BL Davidson, Nat Struct Mol Biol 2006 13 1097 1101 17099701 (Pubitemid 44885920)
8. The microRNA Registry. S Griffiths-Jones, Nucleic Acids Res 2004 32 109 D111 14681370
9. MicroRNAs: molecular features and role in cancer. E Lages, H Ipas, A Guttin, H Nesr, F Berger, JP Issartel, Front Biosci (Landmark Ed) 2012 17 2508 2540
10. Oncomirs-microRNAs with a role in cancer. A Esquela-Kerscher, FJ Slack, Nat Rev Cancer 2006 6 259 269 16557279
11. Regulation of microRNA biogenesis and function. T Treiber, N Treiber, G Meister, Thromb Haemost 2012 107 605 610 22318703
12. Primary microRNA transcripts are processed co-transcriptionally. M Morlando, M Ballarino, N Gromak, F Pagano, I Bozzoni, NJ Proudfoot, Nat Struct Mol Biol 2008 15 902 909 19172742
13. Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma. AM Liu, C Zhang, J Burchard, ST Fan, KF Wong, H Dai, RT Poon, JM Luk, OMICS 2011 15 187 191 21319996
14. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. KJ Dedes, R Natrajan, MB Lambros, FC Geyer, MA Lopez-Garcia, K Savage, RL Jones, JS Reis-Filho, Eur J Cancer 2011 47 138 150 20832293
15. Correlation between hepatitis B virus protein and microRNA processor Drosha in cells expressing HBV. M Ren, D Qin, K Li, J Qu, L Wang, Z Wang, A Huang, H Tang, Antiviral Res 2012 94 225 231 22554933
16. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. EJ Lee, M Baek, Y Gusev, DJ Brackett, GJ Nuovo, TD Schmittgen, RNA 2008 14 35 42 18025253
17. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. SA Melo, C Moutinho, S Ropero, GA Calin, S Rossi, R Spizzo, AF Fernandez, V Davalos, A Villanueva, G Montoya, H Yamamoto, S Schwartz Jr, M Esteller, Cancer Cell 2010 18 303 315 20951941
18. A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. T Wild, P Horvath, E Wyler, B Widmann, L Badertscher, I Zemp, K Kozak, G Csucs, E Lund, U Kutay, PLoS Biol 2010 8 1000522 21048991
19. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. D Cifuentes, H Xue, DW Taylor, H Patnode, Y Mishima, S Cheloufi, E Ma, S Mane, GJ Hannon, ND Lawson, SA Wolfe, AJ Giraldez, Science 2010 328 1694 1698 20448148
20. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. S Cheloufi, SC Dos, MM Chong, GJ Hannon, Nature 2010 465 584 589 20424607
21. Cancer: Small losses, big gains with microRNAs. N McCarthy, Nat Rev Genet 2010 11 8 20050276
22. Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo. I Lambertz, D Nittner, P Mestdagh, G Denecker, J Vandesompele, MA Dyer, JC Marine, Cell Death Differ 2010 17 633 641 20019750
23. Down-regulation of Dicer in hepatocellular carcinoma. JF Wu, W Shen, NZ Liu, GL Zeng, M Yang, GQ Zuo, XN Gan, H Ren, KF Tang, Med Oncol 2011 28 804 809 20405249
24. Conditional deletion of Dicer in vascular smooth muscle cells leads to the developmental delay and embryonic mortality. Y Pan, L Balazs, G Tigyi, J Yue, Biochem Biophys Res Commun 2011 408 369 374 21371421
25. Downregulation of Dicer enhances tumor cell proliferation and invasion. L Han, A Zhang, X Zhou, P Xu, GX Wang, PY Pu, CS Kang, Int J Oncol 2010 37 299 305 20596657
26. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. DJ Papachristou, A Korpetinou, E Giannopoulou, AG Antonacopoulou, H Papadaki, P Grivas, CD Scopa, HP Kalofonos, Virchows Arch 2011 459 431 440 21769619
27. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. S Chiosea, E Jelezcova, U Chandran, J Luo, G Mantha, RW Sobol, S Dacic, Cancer Res 2007 67 2345 2350 17332367 (Pubitemid 46424256)
28. The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing. YL Chen, RH Yuan, WC Yang, HC Hsu, YM Jeng, J Pathol 2013 229 486 496 23097274
29. MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma. J Zhang, H Jin, H Liu, S Lv, B Wang, R Wang, H Liu, M Ding, Y Yang, L Li, J Zhang, S Fu, D Xie, M Wu, W Zhou, Q Qian, Oncogenesis 2014 3 97 24732044
30. Single-nucleotide polymorphisms among microRNA: big effects on cancer. FJ Song, KX Chen, Chin J Cancer 2011 30 381 391 21627860
31. The role of microRNAs in the management of liver cancer. KK Banaudha, M Verma, Methods Mol Biol 2012 863 241 251 22359297
32. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma. L Liu, J An, J Liu, J Wen, X Zhai, Y Liu, S Pan, J Jiang, Y Wen, Z Liu, Y Zhang, J Chen, J Xing, G Ji, H Shen, Z Hu, Z Fan, Mol Carcinog 2013 52 Suppl 1 148 E154 23868705
33. Single Nucleotide Polymorphisms of MicroRNA Processing Machinery Genes and Outcome of Hepatocellular Carcinoma. S Liu, J An, J Lin, Y Liu, L Bao, W Zhang, JJ Zhao, PLoS One 2014 9 92791 24676133
34. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma. MS Son, MJ Jang, YJ Jeon, WH Kim, CI Kwon, KH Ko, PW Park, SP Hong, KS Rim, SW Kwon, SG Hwang, NK Kim, Gene 2013 524 156 160 23632240
35. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. XD Li, ZG Li, XX Song, CF Liu, Pathology 2010 42 669 673 21080878
36. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. Y Liu, Y Zhang, J Wen, L Liu, X Zhai, J Liu, S Pan, J Chen, H Shen, Z Hu, PLoS One 2012 7 32230 22393390
37. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Y Xu, L Li, X Xiang, H Wang, W Cai, J Xie, Y Han, S Bao, Q Xie, Gene 2013 527 584 593 23791656
38. Hallmarks of cancer: the next generation. D Hanahan, RA Weinberg, Cell 2011 144 646 674 21376230
39. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. JL Huang, L Zheng, YW Hu, Q Wang, Carcinogenesis 2014 35 507 514 24296588
40. Cyclin D1 overexpression in hepatocellular carcinoma. M Joo, YK Kang, MR Kim, HK Lee, JJ Jang, Liver 2001 21 89 95 11318977 (Pubitemid 32409535)
41. The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation. X Fu, D Tan, Z Hou, Z Hu, G Liu, Y Ouyang, F Liu, PLoS One 2012 7 43204 22912826
42. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Zhou, L Yu, X Gao, J Hu, J Wang, Z Dai, JF Wang, Z Zhang, S Lu, X Huang, Z Wang, S Qiu, X Wang, G Yang, H Sun, Z Tang, Y Wu, H Zhu, J Fan, J Clin Oncol 2011 29 4781 4788 22105822
43. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. X Yang, L Liang, XF Zhang, HL Jia, Y Qin, XC Zhu, XM Gao, P Qiao, Y Zheng, YY Sheng, JW Wei, HJ Zhou, N Ren, QH Ye, QZ Dong, LX Qin, Hepatology 2013 58 158 170 23389848
44. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. J Kota, RR Chivukula, KA O'Donnell, EA Wentzel, CL Montgomery, HW Hwang, TC Chang, P Vivekanandan, M Torbenson, KR Clark, JR Mendell, JT Mendell, Cell 2009 137 1005 1017 19524505
45. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. T Xu, Y Zhu, Y Xiong, YY Ge, JP Yun, SM Zhuang, Hepatology 2009 50 113 121 19441017
46. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. C Xu, S Liu, H Fu, S Li, Y Tie, J Zhu, R Xing, Y Jin, Z Sun, X Zheng, Eur J Cancer 2010 46 2828 2836 20655737
47. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. S Bai, MW Nasser, B Wang, SH Hsu, J Datta, H Kutay, A Yadav, G Nuovo, P Kumar, K Ghoshal, J Biol Chem 2009 284 32015 32027 19726678
48. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. J Xu, X Zhu, L Wu, R Yang, Z Yang, Q Wang, F Wu, Liver Int 2012 32 752 760 22276989
49. MiR-122 in hepatic function and liver diseases. J Hu, Y Xu, J Hao, S Wang, C Li, S Meng, Protein Cell 2012 3 364 371 22610888
50. Role of microRNAs in hepatitis B virus replication and pathogenesis. WH Liu, SH Yeh, PJ Chen, Biochim Biophys Acta 1809 2011 678 685
51. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. S Wang, L Qiu, X Yan, W Jin, Y Wang, L Chen, E Wu, X Ye, GF Gao, F Wang, Y Chen, Z Duan, S Meng, Hepatology 2012 55 730 741 22105316
52. A better cell cycle target for gene therapy of colorectal cancer: cyclin G. R Perez, N Wu, AA Klipfel Jr, RW Beart, J Gastrointest Surg 2003 7 884 889 14592662 (Pubitemid 37338552)
53. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. F Fornari, L Gramantieri, C Giovannini, A Veronese, M Ferracin, S Sabbioni, GA Calin, GL Grazi, CM Croce, S Tavolari, P Chieco, M Negrini, L Bolondi, Cancer Res 2009 69 5761 5767 19584283
54. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Y Xu, F Xia, L Ma, J Shan, J Shen, Z Yang, J Liu, Y Cui, X Bian, P Bie, C Qian, Cancer Lett 2011 310 160 169 21802841
55. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. L Ma, J Liu, J Shen, L Liu, J Wu, W Li, J Luo, Q Chen, C Qian, Cancer Biol Ther 2010 9 554 561 20150764
56. MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. J Lin, S Huang, S Wu, J Ding, Y Zhao, L Liang, Q Tian, R Zha, R Zhan, X He, Carcinogenesis 2011 32 1641 1647 21890460
57. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. F Fornari, L Gramantieri, M Ferracin, A Veronese, S Sabbioni, GA Calin, GL Grazi, C Giovannini, CM Croce, L Bolondi, M Negrini, Oncogene 2008 27 5651 5661 18521080
58. Examining BCL-2 family function with large unilamellar vesicles. JJ Asciolla, TT Renault, JE Chipuk, J Vis Exp 2012 68 4291 doi:10.3791/4291
59. Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells. J Lin, Y Chen, L Wei, X Chen, W Xu, Z Hong, TJ Sferra, J Peng, Int J Oncol 2010 37 1331 1338 20878081
60. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. L Ouyang, Z Shi, S Zhao, FT Wang, TT Zhou, B Liu, JK Bao, Cell Prolif 2012 45 487 498 23030059
61. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. WP Tsang, TT Kwok, J Nutr Biochem 2010 21 140 146 19269153
62. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Y Xiong, JH Fang, JP Yun, J Yang, Y Zhang, WH Jia, SM Zhuang, Hepatology 2010 51 836 845 20041405
63. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. H Su, JR Yang, T Xu, J Huang, L Xu, Y Yuan, SM Zhuang, Cancer Res 2009 69 1135 1142 19155302
64. Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. C Braconi, N Valeri, P Gasparini, N Huang, C Taccioli, G Nuovo, T Suzuki, CM Croce, T Patel, Clin Cancer Res 2010 16 957 966 20103677
65. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. J Gong, JP Zhang, B Li, C Zeng, K You, MX Chen, Y Yuan, SM Zhuang, Oncogene 2013 32 3071 3079 22824797
66. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. S Shimizu, T Takehara, H Hikita, T Kodama, T Miyagi, A Hosui, T Tatsumi, H Ishida, T Noda, H Nagano, Y Doki, M Mori, N Hayashi, J Hepatol 2010 52 698 704 20347499
67. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. CJ Lin, HY Gong, HC Tseng, WL Wang, JL Wu, Biochem Biophys Res Commun 2008 375 315 320 18692484
68. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Y Li, W Tan, TW Neo, MO Aung, S Wasser, SG Lim, TM Tan, Cancer Sci 2009 100 1234 1242 19486339
69. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. L Gramantieri, F Fornari, M Ferracin, A Veronese, S Sabbioni, GA Calin, GL Grazi, CM Croce, L Bolondi, M Negrini, Clin Cancer Res 2009 15 5073 5081 19671867
70. Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis. E Hofer, B Schweighofer, Thromb Haemost 2007 97 355 363 17334501 (Pubitemid 46437796)
71. PI3K/PTEN signaling in angiogenesis and tumorigenesis. BH Jiang, LZ Liu, Adv Cancer Res 2009 102 19 65 19595306
72. MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. B Zhou, R Ma, W Si, S Li, Y Xu, X Tu, Q Wang, Cancer Lett 2013 333 159 169 23352645
73. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. Y Zhou, Y Li, J Ye, R Jiang, H Yan, X Yang, Q Liu, J Zhang, Liver Int 2013 33 1271 1280 23725476
74. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. JH Fang, HC Zhou, C Zeng, J Yang, Y Liu, X Huang, JP Zhang, XY Guan, SM Zhuang, Hepatology 2011 54 1729 1740 21793034
75. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. L Gramantieri, M Ferracin, F Fornari, A Veronese, S Sabbioni, CG Liu, GA Calin, C Giovannini, E Ferrazzi, GL Grazi, CM Croce, L Bolondi, M Negrini, Cancer Res 2007 67 6092 6099 17616664 (Pubitemid 47037488)
76. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. L Liang, CM Wong, Q Ying, DN Fan, S Huang, J Ding, J Yao, M Yan, J Li, M Yao, IO Ng, X He, Hepatology 2010 52 1731 1740 20827722
77. MicroRNA control of epithelial-mesenchymal transition and metastasis. J Zhang, L Ma, Cancer Metastasis Rev 2012 31 653 662 22684369
78. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. CJ Chang, CH Chao, W Xia, JY Yang, Y Xiong, CW Li, WH Yu, SK Rehman, JL Hsu, HH Lee, M Liu, CT Chen, D Yu, MC Hung, Nat Cell Biol 2011 13 317 323 21336307
79. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. H Siemens, R Jackstadt, S Hunten, M Kaller, A Menssen, U Gotz, H Hermeking, Cell Cycle 2011 10 4256 4271 22134354
80. miR-34 miRNAs provide a barrier for somatic cell reprogramming. YJ Choi, CP Lin, JJ Ho, X He, N Okada, P Bu, Y Zhong, SY Kim, MJ Bennett, C Chen, A Ozturk, GG Hicks, GJ Hannon, L He, Nat Cell Biol 2011 13 1353 1360 22020437
81. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. N Li, H Fu, Y Tie, Z Hu, W Kong, Y Wu, X Zheng, Cancer Lett 2009 275 44 53 19006648
82. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. S Varambally, Q Cao, RS Mani, S Shankar, X Wang, B Ateeq, B Laxman, X Cao, X Jing, K Ramnarayanan, JC Brenner, J Yu, JH Kim, B Han, P Tan, C Kumar-Sinha, RJ Lonigro, N Palanisamy, CA Maher, AM Chinnaiyan, Science 2008 322 1695 1699 19008416
83. miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma. ZH Tao, JL Wan, LY Zeng, L Xie, HC Sun, LX Qin, L Wang, J Zhou, ZG Ren, YX Li, J Fan, WZ Wu, J Exp Med 2013 210 789 803 23478189
84. MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells. Y Yan, YC Luo, HY Wan, J Wang, PP Zhang, M Liu, X Li, S Li, H Tang, Hepatology 2013 57 667 677 22996586
85. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. F Zheng, YJ Liao, MY Cai, YH Liu, TH Liu, SP Chen, XW Bian, XY Guan, MC Lin, YX Zeng, HF Kung, D Xie, Gut 2012 61 278 289 21672940
86. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. X Zhang, S Liu, T Hu, S Liu, Y He, S Sun, Hepatology 2009 50 490 499 19472311
87. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Q Zhu, Z Wang, Y Hu, J Li, X Li, L Zhou, Y Huang, Oncol Rep 2012 27 1660 1668 22322403
88. MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma. Q Tian, L Liang, J Ding, R Zha, H Shi, Q Wang, S Huang, W Guo, C Ge, T Chen, J Li, X He, PLoS One 2012 7 48958 23145039
89. Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. Q Bi, S Tang, L Xia, R Du, R Fan, L Gao, J Jin, S Liang, Z Chen, G Xu, Y Nie, K Wu, J Liu, Y Shi, J Ding, D Fan, PLoS One 2012 7 40169 22768249
90. MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb. L Yu, GF Ding, C He, L Sun, Y Jiang, L Zhu, PLoS One 2014 9 91661 24675898
91. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. WC Tsai, PW Hsu, TC Lai, GY Chau, CW Lin, CM Chen, CD Lin, YL Liao, JL Wang, YP Chau, MT Hsu, M Hsiao, HD Huang, AP Tsou, Hepatology 2009 49 1571 1582 19296470
92. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. J Wang, J Li, J Shen, C Wang, L Yang, X Zhang, BMC Cancer 2012 12 227 22681717
93. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Ji, L Zhao, A Budhu, M Forgues, HL Jia, LX Qin, QH Ye, J Yu, X Shi, ZY Tang, XW Wang, J Hepatol 2010 52 690 697 20338660
94. Targeting the phosphoinositide 3-kinase pathway in cancer. P Liu, H Cheng, TM Roberts, JJ Zhao, Nat Rev Drug Discov 2009 8 627 644 19644473
95. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Q Lang, C Ling, Biochem Biophys Res Commun 2012 426 247 252 22940133
96. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Y Fang, JL Xue, Q Shen, J Chen, L Tian, Hepatology 2012 55 1852 1862 22234835
97. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. F Fornari, M Milazzo, P Chieco, M Negrini, GA Calin, GL Grazi, D Pollutri, CM Croce, L Bolondi, L Gramantieri, Cancer Res 2010 70 5184 5193 20501828
98. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. G Kong, J Zhang, S Zhang, C Shan, L Ye, X Zhang, PLoS One 2011 6 19518 21573166
99. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. F Fornari, M Milazzo, P Chieco, M Negrini, E Marasco, G Capranico, V Mantovani, J Marinello, S Sabbioni, E Callegari, M Cescon, M Ravaioli, CM Croce, L Bolondi, L Gramantieri, J Pathol 2012 227 275 285 22262409
100. Autophagy as a target for anticancer therapy. F Janku, DJ McConkey, DS Hong, R Kurzrock, Nat Rev Clin Oncol 2011 8 528 539 21587219
101. Role of miR-148a in hepatitis B associated hepatocellular carcinoma. K Yuan, Z Lian, B Sun, MM Clayton, IO Ng, MA Feitelson, PLoS One 2012 7 35331 22496917
102. microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. XC Zhu, QZ Dong, XF Zhang, B Deng, HL Jia, QH Ye, LX Qin, XZ Wu, Int J Mol Med 2012 30 1321 1326 23023935
103. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. D Li, X Liu, L Lin, J Hou, N Li, C Wang, P Wang, Q Zhang, P Zhang, W Zhou, Z Wang, G Ding, SM Zhuang, L Zheng, W Tao, X Cao, J Biol Chem 2011 286 36677 36685 21878637
104. miR-221 overexpression contributes to liver tumorigenesis. P Pineau, S Volinia, K McJunkin, A Marchio, C Battiston, B Terris, V Mazzaferro, SW Lowe, CM Croce, A Dejean, Proc Natl Acad Sci U S A 2010 107 264 269 20018759
105. Manipulation of autophagy by MIR375 generates antitumor effects in liver cancer. Y Chang, J Lin, A Tsung, Autophagy 2012 8 1833 1834 22929050
106. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Y Chang, W Yan, X He, L Zhang, C Li, H Huang, G Nace, DA Geller, J Lin, A Tsung, Gastroenterology 2012 143 177 187 22504094
107. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. N Xu, J Zhang, C Shen, Y Luo, L Xia, F Xue, Q Xia, Biochem Biophys Res Commun 2012 423 826 831 22713463
108. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling. Y Wang, C Hu, J Cheng, B Chen, Q Ke, Z Lv, J Wu, Y Zhou, Biochem Biophys Res Commun 2014 446 1255 1260 24690171